688073 Bide Pharmatech
- 29.46
- +0.02+0.07%
Bide Pharmatech News
Shanghai Bide Pharmaceutical Technology Co., Ltd. Investor Relations Activity Record Form (August 29, 2024)
Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year of 2024
Opinions of Haitong Securities Co., Ltd. on the verification of the use of idle funds by Shanghai Bide Pharmaceutical Technology Co., Ltd. for cash management
Announcement on plans to use idle own funds for cash management
Announcement on cancellation of wholly-owned subsidiary
2024 Semi-Annual Report
Announcement on preparations for asset impairment accrued for the semi-annual period of 2024
Announcement of Resolutions of the Seventh Meeting of the Second Board of Supervisors
Bide Pharmaceutical: Semi-Annual Evaluation Report on the 2024 “Improve Quality, Increase Efficiency, and Value Return” Action Plan
2024 Semi-Annual Report Summary
Announcement on the implementation results of share repurchase.
Announcement on the Progress of Repurchasing Shares through the Centralized Bidding Trading Method.
Legal Opinion on the Shareholding Increase of BiDe Pharmaceutical's Actual Controller, Chairman and General Manager.
Announcement on the Completion of the Implementation of the Shareholding Plan by the Actual Controller and Director General Manager and the Results of the Shareholding
Announcement on the adjustment of the upper limit of the repurchase price after the implementation of the annual equity distribution in 2023.
Special Explanation on Financial Issues Relevant to the Inquiry Letter on 2023 Annual Report of BiDe Pharmaceutical by Zhonghui Certified Public Accountants
Announcement of Reply to Information Disclosure Inquiry Letter on 2023 Annual Report Regulation.
Simplified Equity Change Report
Announcement on Shareholder Dissolution and Equity Changes
Haitong Securities Co., Ltd.'s verification opinion on the differential dividend of Shanghai Bide Pharmaceutical Technology Co., Ltd.
Analysis
Price Target
No Data
No Data